ADS Biotec, along with its parent company ADSTEC (Japan), is a global leader in the development, manufacture and sale of automated instruments and consumables for use in cytogenetic, pathology and research laboratories.
Each year, the TIDES USA conference scientific agenda includes 150+ of the industry’s top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing product. We’re excited to invite you to join […]
It’s that time of year again when we come together for our Great Lakes Genomics Conference Meeting. We’re excited to invite you to join us as we reflect on our achievements, discuss our future plans, and strengthen the bond within our community. We can’t wait to see you there! This conference focuses on molecular and […]
PRESS RELEASE ADS Biotec Launches HANABI Avatar™ Organoid Growth Media January 09, 2023 – Omaha, USA: ADS Biotec, is a global leader in development of automated instruments and bio-consumables to increase productivity for Cytogenetic, Pathology, and Molecular Genetics in clinical and research laboratories is pleased to announce immediate availability of its HANABI Avatar™ Organoid Growth Medias, […]
ADS Biotec – Genetic Solutions/Service Company ADS Biotec has a global footprint with offices in the U.S., Europe, and Japan, with customers in over 30 countries and more that 250 active installations in leading medical facilities, diagnostic labs and academic research labs. Having established itself within the genetics discipline, its product line, HANABI, is recognized as [...]
ADS Biotec Receives ISO 13485:2016 Quality System Certification ISO 13485 certification indicates that the company’s quality management system meets the most current regulatory requirements specific to the international medical device industry. Read More HANABI Cytogenetic Automation Instruments with CE-IVD Mark ADSTEC along with its subsidiary ADS Biotec now offer a range of HANABI Cytogenetic Automation [...]
Innovative and cost-effective automation with its game-changing solutions, ADS Biotec offers robust solutions that can solve the service challenges for laboratories. A global leader in the field of automated instruments, its team designs, produces, and distributes automated systems and supplies used in cytogenetic, pathology, and research labs, along with producing custom solutions. Its automated technology and […]
PRESS RELEASE Ads Biotec receives ISO 13485:2016 Quality System Certification ISO 13485 certification indicates that the company’s quality management system meets the most current regulatory requirements specific to the international medical device industry. January 16, 2023 – Omaha, USA: ADS Biotec, a global leader in development of automated instruments and bio-consumables including buffers for mRNA […]
ADS Biotec strengthens its Scientific Advisory Board with appointments of new board members. Appointment of two new Scientific Advisory Board members will help to guide the company’s ambitious growth plans. March 2, 2023 – Omaha, USA: ADS Biotec, a global leader in development of automated instruments and bio-consumables including buffers for mRNA purification, is […]
ADSTEC along with its subsidiary ADS Biotec now offer a range of HANABI Cytogenetic Automation Instruments with CE-IVD mark. September 27, 2022 –Tokyo, Japan and Omaha, USA: ADSTEC and its subsidiary ADS Biotec, a global leader in development of automated instruments and consumables for use in cytogenetic, pathology and research laboratories is pleased to announce […]
GEN Genetic Engineering and Biotechnology News with John McCloskey. Original article by Kathy Liszews – GEN Cytogenetics automation Diseases such as cancer often feature chromosomal breaks, rearrangements, and added or missing segments. Cytogenetic (that is, chromosomal) analyses can help clinicians improve their diagnostic capabilities, treatment decisions, and outcome assessments. “Certain processes in the cytogenetics workflow, […]
